Abstract:Organic chromium is of great interest and has become an important chromium supplement resource in recent years because of its low toxicity and easy absorption. In our previous study, we synthesized a novel organic chromium [GLP-Cr] through the chelation of Ganoderma lucidum polysaccharide and chromium (III). The purpose of this study was to investigate the beneficial effects of GLP-Cr on the improvement of metabolic syndromes (MetS) in mice fed with a high-fat and high-fructose diet (HFHFD) and its mechanism of action. The results indicated that oral administration of GLP-Cr inhibited the excessive exaltation of body weight, glucose tolerance, fasting blood glucose and lipid levels, hepatic total cholesterol (TC), triglyceride (TG) levels caused by HFHFD. Besides, 16S rRNA amplicon sequencing showed that GLP-Cr intervention evidently ameliorated intestinal microbiota dysbiosis by changing the proportions of some intestinal microbial phylotypes. In addition, correlation network-based analysis indicated that the key intestinal microbial phylotypes were closely related to biochemical parameters associated with MetS under GLP-Cr intervention. Liver metabolomics analysis suggested that GLP-Cr intervention significantly regulated the levels of some biomarkers involved in alpha-linolenic acid metabolism, fatty acid biosynthesis, steroid hormone biosynthesis, glycerophospholipid metabolism, glycerolipid metabolism, steroid hormone biosynthesis, primary bile acid biosynthesis, and so on. Moreover, GLP-Cr intervention regulated liver mRNA levels of key genes associated with glucose and lipid metabolism. The mRNA level of glucose transporter type 4 ( Glut4 ) was markedly increased by GLP-Cr intervention, and the mRNA levels of phosphoenolpyruvate carboxykinase ( Pepck ) and glucose-6-phosphatase ( G6Pase ) in the liver were significantly decreased. Meanwhile, GLP-Cr intervention significantly decreased hepatic mRNA levels of cluster of differentiation 36 ( Cd36 ), acetyl-CoA carboxylase 1 ( Acc1 ) and sterol regulatory element binding protein-1c ( Srebp-1c ), indicating that GLP-Cr intervention inhibited the excessive accumulation of free fatty acids in the liver. These findings suggest that the prevention of hyperglycemia and dyslipidemia by GLP-Cr may be closely related to the regulation of gut microbial composition and hepatic metabolic pathways, thus GLP-Cr can be serving as a functional component in the prevention of MetS.

Insulin-Sensitizing and Cholesterol-Lowering Effects of Chromium (D-Phenylalanine)(3)

Chromium (D-Phenylalanine)3 Supplementation Alters Glucose Disposal, Insulin Signaling, and Glucose Transporter-4 Membrane Translocation in Insulin-Resistant Mice.

Chromium Alleviates Glucose Intolerance, Insulin Resistance, and Hepatic Er Stress in Obese Mice

Chromium(D-Phenylalanine)(3) Improves Obesity-Induced Cardiac Contractile Defect in Ob/Ob Mice

A Newly Synthetic Chromium Complex – Chromium(phenylalanine)3 Improves Insulin Responsiveness and Reduces Whole Body Glucose Tolerance

Chromium (d-Phenylalanine)3 alleviates high fat-induced insulin resistance and lipid abnormalities

A Newly Synthetic Chromium Complex—chromium (D-Phenylalanine)3 Activates AMP-activated Protein Kinase and Stimulates Glucose Transport

Hypolipidemic effect of chromium-modified enzymatic product of sulfated rhamnose polysaccharide from Enteromorpha prolifera in type 2 diabetic mice

Molecular mechanisms of chromium in alleviating insulin resistance.

Chromium Alters Lipopolysaccharide-Induced Inflammatory Responses Both in Vivo and in Vitro.

Organic chromium derived from the chelation of Ganoderma lucidum polysaccharide and chromium (III) alleviates metabolic syndromes and intestinal microbiota dysbiosis induced by high-fat and high-fructose diet

Evaluation of Hypoglycemic Activity and Sub-Acute Toxicity of the Novel Biochanin A-Chromium(III) Complex

Effects of Organic Chromium on Glycometabolism and Lipid Metabolism in Diabetic Rats

Potential antidiabetic molecule involving a new chromium(III) complex of dipicolinic and metformin as a counter ion: Synthesis, structure, spectroscopy, and bioactivity in mice

Chromium in Human Nutrition: A Review

Potential Ameliorative Effects of Chromium Supplementation on Glucose Metabolism, Obesity, and Genomic Stability in Prediabetic Rat Model

The effects of chromium and vitamin D3 co-supplementation on insulin resistance and tumor necrosis factor-alpha in type 2 diabetes: a randomized placebo-controlled trial

Effect of Chromium-Enriched Yeast on Fasting Plasma Glucose, Glycated Haemoglobin and Serum Lipid Levels in Patients with Type 2 Diabetes Mellitus Treated with Insulin

Spectroscopic and biological activity studies of the chromium-binding peptide EEEEGDD

The role of Chromium III in the organism and its possible use in diabetes and obesity treatment

Chromium(Iii) Complexes of D-Glucosaminic Acid and Their Effect on Decreasing Blood Sugar in Vivo